The current managing director of Société Générale must leave his duties in May 2023. His appointment within the pharmaceutical group will be offered at the next general meeting of shareholders, which is usually held in the spring.
Le Monde with AFP
Frédéric Oudéa, current managing director of Société Générale, will be proposed as the next non -executive chairman of the Sanofi board of directors, the pharmaceutical group announced on Monday, September 5 in a press release.
Sanofi specifies that Mr. Oudéa was appointed on September 2 censor by the group’s board of directors, and that his appointment as a administrator will be proposed at the next general meeting of shareholders.
Departure from Société Générale in 2023
Following this general meeting – the precise date of which is not yet fixed, but which is usually held in the spring – “it will be proposed to the board of directors of Sanofi the appointment of Frédéric Oudéa as Non -executive president of this council, replacing Serge Weinberg whose mandate will have expired “. “Frédéric Oudéa announced that he would leave his duties as general manager and director of Société Générale in May 2023”, after his current mandate, recalls Sanofi.
“Frédéric Oudéa and Paul Hudson, Managing Director of Sanofi, will form an excellent duo to position Sanofi as a modern health company and strengthen their position as a French, European and world leader in the service of patients”, said Serge Weinberg, quoted in the press release.
“I am very happy to join the Sanofi board of directors as censor, with, subject to the agreement of its shareholders, the prospect of taking the presidency. I am extremely motivated by the prospect of contributing In the coming years to Sanofi’s strategy and sustainable development, a leading company in a strategic health sector, with high impact and in full transformation, and to be the guarantor of the quality of group governance, “said M. Oudéa.